{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-064025","form_type":"8-K","ticker":"CGEM","cik":"0001789972","company_name":"Cullinan Therapeutics, Inc.","filed_at":"2024-05-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.129860+00:00","generated_at":"2026-06-01T09:17:59.016847+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Cullinan announces CLN-619+Keytruda shows PRs in EGFR/ALK NSCLC; monotherapy CR in parotid","bullets":["Combination with pembrolizumab: 3 confirmed PRs in NSCLC (EGFR/ALK) and gastric patients typically CPI-unresponsive.","Monotherapy: 1 CR (mucoepidermoid parotid, 71 wks), 2 PRs (endometrial), 9 SD ≥18 wks; clinical benefit rate 41.4%.","Safety profile well tolerated; most TRAEs grade 1/2; no treatment-related deaths.","Based on data, expansion cohorts in NSCLC initiated; Phase 1 in relapsed/refractory multiple myeloma planned.","Data to be presented at ASCO 2024 on June 3; investor event June 1."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-064025","json":"https://secwatch.observer/filing/0000950170-24-064025.json","markdown":"https://secwatch.observer/filing/0000950170-24-064025.md","text":"https://secwatch.observer/filing/0000950170-24-064025.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1789972/000095017024064025/0000950170-24-064025-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1789972/000095017024064025/cgem-20240523.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T09:17:59.016847+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}